Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. - Yang S; Zhang X; Gale RP; Du X; Chen CY; Weng JY; Huang J; Li F; Zeng Y; Xiao Z; Hu JD; Yang LJ; et al. (American journal of hematology, 2023)